JP2023522644A5 - - Google Patents

Info

Publication number
JP2023522644A5
JP2023522644A5 JP2022562465A JP2022562465A JP2023522644A5 JP 2023522644 A5 JP2023522644 A5 JP 2023522644A5 JP 2022562465 A JP2022562465 A JP 2022562465A JP 2022562465 A JP2022562465 A JP 2022562465A JP 2023522644 A5 JP2023522644 A5 JP 2023522644A5
Authority
JP
Japan
Prior art keywords
acetyl
mutilin
pharmaceutical composition
composition according
diastereomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562465A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522644A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/025140 external-priority patent/WO2021209174A1/en
Publication of JP2023522644A publication Critical patent/JP2023522644A/ja
Publication of JP2023522644A5 publication Critical patent/JP2023522644A5/ja
Priority to JP2025230606A priority Critical patent/JP2026041886A/ja
Pending legal-status Critical Current

Links

JP2022562465A 2020-04-17 2021-04-16 プレウロムチリンの治療的使用 Pending JP2023522644A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025230606A JP2026041886A (ja) 2020-04-17 2025-12-04 プレウロムチリンの治療的使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202063011474P 2020-04-17 2020-04-17
US63/011,474 2020-04-17
EP20170072 2020-04-17
EP20170072.1 2020-04-17
EP20183292 2020-06-30
EP20183292.0 2020-06-30
PCT/EP2021/025140 WO2021209174A1 (en) 2020-04-17 2021-04-16 Therapeutic use of pleuromutilins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025230606A Division JP2026041886A (ja) 2020-04-17 2025-12-04 プレウロムチリンの治療的使用

Publications (2)

Publication Number Publication Date
JP2023522644A JP2023522644A (ja) 2023-05-31
JP2023522644A5 true JP2023522644A5 (https=) 2025-07-30

Family

ID=75801547

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022562465A Pending JP2023522644A (ja) 2020-04-17 2021-04-16 プレウロムチリンの治療的使用
JP2025230606A Pending JP2026041886A (ja) 2020-04-17 2025-12-04 プレウロムチリンの治療的使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025230606A Pending JP2026041886A (ja) 2020-04-17 2025-12-04 プレウロムチリンの治療的使用

Country Status (9)

Country Link
US (1) US20230174472A1 (https=)
EP (1) EP4135682A1 (https=)
JP (2) JP2023522644A (https=)
CN (1) CN115443131A (https=)
BR (1) BR112022020007A2 (https=)
CA (1) CA3180535A1 (https=)
IL (1) IL297268A (https=)
TW (1) TW202203908A (https=)
WO (1) WO2021209174A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4475834A1 (en) 2022-02-09 2024-12-18 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia
CN119925362A (zh) * 2023-11-03 2025-05-06 阳光安津(南京)生物医药科技有限公司 一种化合物在制备用于治疗银屑病的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790767B2 (en) * 2005-06-27 2010-09-07 Nabriva Therapeutics Forschungs Gmbh Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
EP1972618A1 (en) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
GB0803707D0 (en) * 2008-02-28 2008-04-09 Cambridge Entpr Ltd Antiviral agent
EP2399904A1 (en) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Process for the preparation of pleuromutilins
CN103204787B (zh) 2012-01-17 2014-10-01 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
CN103242210B (zh) 2012-02-09 2014-09-24 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
ES2843723T3 (es) 2015-06-17 2021-07-20 Nabriva Therapeutics GmbH Formulaciones farmacéuticas inyectables de lefamulina
CN110507823B (zh) * 2019-08-20 2021-08-24 中国医学科学院基础医学研究所 衣康酸相关物质在诊断、防治病毒感染性疾病中的应用

Similar Documents

Publication Publication Date Title
JP2023522644A5 (https=)
CN112778310A8 (zh) 核苷类似物或含有核苷类似物的组合制剂在抗病毒中的应用
US20230172849A1 (en) Inhaled statins for treatment of viral respiratory diseases
US20230149345A1 (en) Methods of treatment of coronavirus-induced inflammation conditions
JP7844340B2 (ja) 急性肺傷害の治療のための５－アミノ－２，３－ジヒドロ－１，４－フタラジンジオン
JP2010285436A5 (https=)
EA022840B1 (ru) Фармацевтическая композиция, набор, их применение и способ профилактики и лечения симптома, состояния или заболевания, связанного с инфекцией вируса гриппа
CN102655859A (zh) 病毒感染的组合疗法治疗
JP2009544665A5 (https=)
BR112013032306A2 (pt) derivados de indanona, sais farmaceuticamente aceitáveis ou isômeros óticos dos mesmos, método de preparação dos mesmos, e composições farmacêuticas contendo os mesmos como ingredientes ativos para prevenção ou tratamento de doenças virais
JP2017515840A5 (https=)
WO2021216530A1 (en) Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizer
AU2016287580A2 (en) Compositions and methods for the treatment of viral infection
WO2020037095A1 (en) Egcg-palmitate compositions and methods of use thereof
JP2023502053A (ja) デング病の治療及び予防
EP3934653B1 (en) Azelastine as antiviral treatment
EP4167983A1 (en) Antiviral use of calixarenes
CN108472375A (zh) 中重度流感的治疗方法
JP2010189301A (ja) 新型インフルエンザ感染症に対する医薬組成物およびその利用
CN116589518B (zh) 一种新型的胞苷衍生物及其药物组合物和用途
WO2022133494A1 (en) Antiviral compounds and applications thereof
JP2009538822A (ja) 静脈におけるウイルスの治療
JP2011016804A5 (https=)
WO2022145407A1 (ja) Ｄｐ１アンタゴニストおよびノイラミニダーゼ阻害剤からなるウイルス性気道感染症治療用医薬
JP2011020938A (ja) 抗インフルエンザウイルス剤